Efficacy of Transcranial Direct Current Stimulation (tDCS) on Neuropsychiatric Symptoms in Substance Use Disorder (SUD)—A Review and Insights into Possible Mechanisms of Action DOI Open Access

James Chmiel,

Marta Stępień-Słodkowska, Irena Ramik-Mażewska

et al.

Journal of Clinical Medicine, Journal Year: 2025, Volume and Issue: 14(4), P. 1337 - 1337

Published: Feb. 18, 2025

Introduction: Substance use disorder (SUD) is a significant global clinical issue marked by the excessive consumption of alcohol, nicotine, and various psychoactive substances, leading to impaired social, cognitive, occupational functioning. Individuals with SUD frequently experience depression anxiety disorders, which exacerbate their prognosis contribute substantial health social burdens. The pathophysiology its associated conditions multifaceted, involving multiple dysfunctions in brain. This complexity underscores an urgent need for development noninvasive treatments that can directly target One them transcranial direct current stimulation (tDCS), intensively studied technique safely modulating cortical excitability. aim this study investigate effectiveness tDCS treating symptoms SUD. Methods: With emphasis on underlying mechanisms action, mechanistic review investigates patients. Literature searches were conducted using PubMed/Medline, ResearchGate, Cochrane, Google Scholar databases. Results: identified 12 relevant studies. results showed left dorsolateral prefrontal cortex (DLPFC) effective treatment option In right DLPFC effective, better observed stimulation. However, included studies differed methodology, sample characteristics, measurement methods, could have influenced final analysis. central focus discuss potential action These include modulation brain networks, reduction neuroinflammation, enhancement neuroplasticity, increase P300 amplitude. We also limitations propose ways address future research. Conclusions: provides evidence Stimulation reduces depression, while anxiety. research required confirm these findings deepen our understanding through exerts effects context. Neuroimaging methods (fMRI EEG) blood tests be particularly useful.

Language: Английский

Neurotransmitters—Key Factors in Neurological and Neurodegenerative Disorders of the Central Nervous System DOI Open Access
Raluca Ioana Teleanu, Adelina-Gabriela Niculescu, Eugenia Roza

et al.

International Journal of Molecular Sciences, Journal Year: 2022, Volume and Issue: 23(11), P. 5954 - 5954

Published: May 25, 2022

Neurotransmitters are molecules that amplify, transmit, and convert signals in cells, having an essential role information transmission throughout the nervous system. Hundreds of such chemicals have been discovered last century, continuing to be identified studied concerning their action on brain health. These substances observed influence numerous functions, including emotions, thoughts, memories, learning, movements. Thus, disturbances neurotransmitters' homeostasis started being correlated with a plethora neurological neurodegenerative disorders. In this respect, present paper aims describe most important neurotransmitters, broadly classified into canonical (e.g., amino acids, monoamines, acetylcholine, purines, soluble gases, neuropeptides) noncanonical neurotransmitters exosomes, steroids, D-aspartic acid), explain link some relevant conditions. Moreover, brief overview recently developed detection methods is offered, followed by several considerations modulation these towards restoring homeostasis.

Language: Английский

Citations

270

ALOX5-mediated ferroptosis acts as a distinct cell death pathway upon oxidative stress in Huntington's disease DOI Open Access

Shujuan Song,

Zhenyi Su, Ning Kon

et al.

Genes & Development, Journal Year: 2023, Volume and Issue: 37(5-6), P. 204 - 217

Published: March 1, 2023

Although it is well established that Huntington's disease (HD) mainly caused by polyglutamine-expanded mutant huntingtin (mHTT), the molecular mechanism of mHTT-mediated actions not fully understood. Here, we showed expression N-terminal fragment containing expanded polyglutamine (HTTQ94) mHTT able to promote both ACSL4-dependent and ACSL4-independent ferroptosis. Surprisingly, inactivation ferroptosis fails show any effect on life span mice. Moreover, using RNAi-mediated screening, identified ALOX5 as a major factor required for induced HTTQ94. ferroptotic responses triggered common inducers such erastin, loss abolishes HTTQ94-mediated upon reactive oxygen species (ROS)-induced stress. Interestingly, also in neuronal cells high levels glutamate. Mechanistically, HTTQ94 activates ALOX5-mediated stabilizing FLAP, an essential cofactor lipoxygenase activity. Notably, Alox5 gene abrogates activity striatal neurons from HD mice; more importantly, significantly ameliorates pathological phenotypes extends spans these Taken together, results demonstrate critical suggest potential new target disease.

Language: Английский

Citations

57

Possible role of exercise therapy on depression: Effector neurotransmitters as key players DOI
Hamed Alizadeh Pahlavani

Behavioural Brain Research, Journal Year: 2023, Volume and Issue: 459, P. 114791 - 114791

Published: Dec. 2, 2023

Language: Английский

Citations

56

Innovation at the Intersection: Emerging Translational Research in Neurology and Psychiatry DOI Creative Commons
Masaru Tanaka, Simone Battaglia, Lydia Giménez‐Llort

et al.

Cells, Journal Year: 2024, Volume and Issue: 13(10), P. 790 - 790

Published: May 7, 2024

Translational research in neurological and psychiatric diseases is a rapidly advancing field that promises to redefine our approach these complex conditions [...]

Language: Английский

Citations

19

Trem2 expression in microglia is required to maintain normal neuronal bioenergetics during development DOI Creative Commons
Erica Tagliatti, Genni Desiato, Sara Mancinelli

et al.

Immunity, Journal Year: 2023, Volume and Issue: 57(1), P. 86 - 105.e9

Published: Dec. 29, 2023

Triggering receptor expressed on myeloid cells 2 (Trem2) is a cell-specific gene in brain microglia, with variants that are associated neurodegenerative diseases, including Alzheimer's disease. Trem2 essential for microglia-mediated synaptic refinement, but whether contributes to shaping neuronal development remains unclear. Here, we demonstrate plays key role controlling the bioenergetic profile of pyramidal neurons during development. In absence Trem2, developing hippocampal cornus ammonis (CA)1 not CA3 subfield displayed compromised energetic metabolism, accompanied by reduced mitochondrial mass and abnormal organelle ultrastructure. This was paralleled transcriptional rearrangement at birth, pervasive alteration metabolic, oxidative phosphorylation, signatures, delay maturation CA1 neurons. Our results unveil regulating metabolic fitness region-specific manner.

Language: Английский

Citations

40

Glutamatergic neurotransmission: A potential pharmacotherapeutic target for the treatment of cognitive disorders DOI
Pratik Chakraborty, Abhijit Dey, Abilash Valsala Gopalakrishnan

et al.

Ageing Research Reviews, Journal Year: 2023, Volume and Issue: 85, P. 101838 - 101838

Published: Jan. 5, 2023

Language: Английский

Citations

27

Inflammatory Pathogenesis of Post-stroke Depression DOI Creative Commons
Xinyu Feng, Xiaojuan Ma, Juan Li

et al.

Aging and Disease, Journal Year: 2024, Volume and Issue: unknown

Published: Jan. 1, 2024

Post-stroke depression (PSD) is a complex mood disorder that emerges in individuals following stroke, characterized by the development of depressive symptoms. The pathogensis PSD diverse, with inflammation playing vital role its onset and progression. Emerging evidence suggests microglial activation, astrocyte responses, nuclear factor κB(NF-κB) signaling, dysregulation hypothalamic pituitary adrenal (HPA) axis, alterations brain-derived neurotrophic (BDNF) expression, neurotransmitter imbalances, adenosine triphosphate (ATP) receptors oxidative stress are intricately linked to pathogenesis PSD. involvement inflammatory cytokines these processes highlights significance pathway. Integrating hypotheses, mechanism offers novel perspective expand therapeutic strategies for

Language: Английский

Citations

11

Advances in biosensors for major depressive disorder diagnostic biomarkers DOI
Tao Dong,

Chenghui Yu,

Qi Mao

et al.

Biosensors and Bioelectronics, Journal Year: 2024, Volume and Issue: 258, P. 116291 - 116291

Published: April 16, 2024

Language: Английский

Citations

9

Glutamate transporter activator LDN-212320 prevents chronic pain-induced cognitive impairment and anxiety-like behaviors in a mouse model DOI
Ghallab Alotaibi, Amna Khan, Shafiqur Rahman

et al.

Behavioural Brain Research, Journal Year: 2025, Volume and Issue: unknown, P. 115440 - 115440

Published: Jan. 1, 2025

Language: Английский

Citations

1

Contribution of Brain Intrinsic Branched‐Chain Amino Acid Metabolism in a Novel Mouse Model of Maple Syrup Urine Disease DOI Open Access

Amanda Kuhs,

Laura Ohl,

Tegan Thurston

et al.

Journal of Inherited Metabolic Disease, Journal Year: 2025, Volume and Issue: 48(2)

Published: Feb. 4, 2025

Language: Английский

Citations

1